Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption.

The experimental flowchart is shown in figure 1. The schedule of enrolment, interventions and assessments is shown in figure 2.

Serum and fecal metabolomic analyses were conducted, and the fecal samples underwent additional examination for gut microbiota composition. Figure 1. Experimental Procedures and Acupoint Selection. (A ...